Sort   by:  
 Page size 
UnknownSuppression tumorigenicity 2 (ST2) turbidimetric immunoassay compared to enzyme-linked immunosorbent assay in predicting survival in heart failure patients with reduced ejection fraction.
Not available
S-EPMC7572613 | biostudies-literature
UnknownPolygenic Score for β-Blocker Survival Benefit in European Ancestry Patients With Reduced Ejection Fraction Heart Failure.
Not available
S-EPMC7738407 | biostudies-literature
UnknownGenetic drivers of human plasma metabolites that determine mortality in heart failure patients with reduced ejection fraction.
Not available
S-EPMC11263106 | biostudies-literature
UnknownEvaluation of a New Aptamer-Based Array for Soluble Suppressor of Tumorgenicity (ST2) and N-terminal Pro-B-Type Natriuretic Peptide (NTproBNP) in Heart Failure Patients.
Not available
S-EPMC10651796 | biostudies-literature
UnknownAssociation of genetic variation with gene expression and protein abundance within the natriuretic peptide pathway.
Not available
S-EPMC3795918 | biostudies-literature
UnknownEfficacy of a Brief Tele-Cognitive Behavioral Treatment vs Attention Control for Head and Neck Cancer Survivors With Body Image Distress: A Pilot Randomized Clinical Trial.
Not available
S-EPMC9716435 | biostudies-literature
UnknownRisk Prediction in Transition: MAGGIC Score Performance at Discharge and Incremental Utility of Natriuretic Peptides.
Not available
S-EPMC10062381 | biostudies-literature
UnknownPlasma Proteomic Profile Predicts Survival in Heart Failure With Reduced Ejection Fraction.
Not available
S-EPMC8221080 | biostudies-literature
UnknownGenetic and nongenetic factors influencing pharmacokinetics of B-type natriuretic peptide.
Not available
S-EPMC4189182 | biostudies-literature
UnknownGenetic Factors Influencing B-type Natriuretic Peptide-Mediated Production of Cyclic Guanosine Monophosphate and Blood Pressure Effects in Heart Failure Patients.
Not available
S-EPMC4686234 | biostudies-literature
Sort   by:  
 Page size